10-K Filing

ALPHAVEST ACQUISITION CORP. CIK: 1937891 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001493152-23-010328`
Period End Date	20221231
Filing Date	20230331
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 28 Income Statement 5 Cash Flow Statement 21 Stockholders Equity 10

Balance Sheet 28 line items

Line Item	Tag	Value	Unit	Period
Temproary equity, redemption shares	`TemporaryEquitySharesOutstanding`	6.90M	shares	Point-in-time
Temproary equity, redemption price per share	`TemporaryEquityRedemptionPricePerShare`	$10.20	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$659.03K	USD	Point-in-time
Preferred stock, shares par or stated value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$82.77K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$741.81K	USD	Point-in-time
Prepaid expenses - Non-current	`PrepaidExpenseNoncurrent`	$32.38K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities held in trust account	`AssetsHeldInTrustNoncurrent`	$70.42M	USD	Point-in-time
Total Assets	`Assets`	$71.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.28M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.28M	shares	Point-in-time
Accounts Payable and accrued offering costs and expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$248.03K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$9.84K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$257.87K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock subject to possible redemption (6,900,000 shares at $10.20 per share)	`TemporaryEquityCarryingAmountAttributableToParent`	$70.38M	USD	Point-in-time
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 2,280,500 shares issued and outstanding	`CommonStockValue`	$228.00	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$596.89K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-42.58K	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$554.54K	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	-	USD	Point-in-time
Total Liabilities, Redeemable Common Stock, and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$71.19M	USD	Point-in-time

Income Statement 5 line items

Line Item	Tag	Value	Unit	Period
Formation and operating costs	`OperatingCostsAndExpenses`	$80.81K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-80.81K	USD	Annual
Interest income on investments held in trust account	`InvestmentIncomeInterest`	$38.23K	USD	Annual
Total other income	`OtherNonoperatingIncomeExpense`	$38.23K	USD	Annual
Net loss	`NetIncomeLoss`	$-42.58K	USD	Annual

Cash Flow Statement 21 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-42.58K	USD	Annual
Prepaid expense	`IncreaseDecreaseInPrepaidExpense`	$115.15K	USD	Annual
Accounts payable and accrued offering costs and expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$161.12K	USD	Annual
Due to related party	`IncreaseDecreaseInDueToRelatedParties`	$34.84K	USD	Annual
Trust investment income	`IncreaseDecreaseInMarketableSecuritiesRestricted`	$38.23K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	-	USD	Annual
Cash deposited to trust account	`PaymentsToAcquireRestrictedInvestments`	$70.38M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.38M	USD	Annual
Proceeds from sale of common stock to initial shareholders	`ProceedsFromIssuanceOfCommonStock`	$1.75K	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$58.50M	USD	Annual
Proceeds from private placement	`ProceedsFromIssuanceOfPrivatePlacement`	$3.90M	USD	Annual
Proceeds from over-allotment and private placement, net of underwriters discount	`ProceedsFromOverallotmentAndPrivatePlacementNetOfUnderwritersDiscount`	$9.18M	USD	Annual
Payments of offering costs and other fees	`PaymentsOfStockIssuanceCosts`	$542.72K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$71.04M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$659.03K	USD	Annual
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$659.03K	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$659.03K	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Deferred offering costs paid by Sponsor in exchange for issuance of common stock	`DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfCommonStock`	$25.00K	USD	Annual
Deferred offering costs included in due to accrued expenses	`DeferredOfferingCostsIncludedInDueToAccruedExpenses`	$40.00K	USD	Annual

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$554.54K	USD	Point-in-time
Balance	`StockholdersEquity`	-	USD	Point-in-time
Common stock issued to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	Annual
Common stock issued to Underwriter	`StockIssuedDuringPeriodValueIssuedForServices`	$1.75K	USD	Annual
Sale of 390,000 private units	`StockIssuedDuringPeriodValueOther`	$3.90M	USD	Annual
Sale of 40,500 private units	`StockIssuedDuringPeriodValuePrivateUnits`	$405.00K	USD	Annual
Offering costs	`AdjustmentsToAdditionalPaidInCapitalOther`	$-3.73M	USD	Annual
Net loss	`NetIncomeLoss`	$-42.58K	USD	Annual
Balance	`StockholdersEquity`	$554.54K	USD	Point-in-time
Balance	`StockholdersEquity`	-	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.